Hepion Pharmaceuticals Inc

NASDAQ:HEPA

0.72

-0.03 (-4.44%)

6:17:37 PM EDT: $0.75 +0.03 (+3.67%)

Hepion Pharmaceuticals Inc Stock, NASDAQ:HEPA

399 Thornall Street, 1st Floor, Edison, New Jersey 08837

United States of America

Phone: +1.732.902.4000

Number of Employees: 22

http://www.hepionpharma.com

Description

Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. It focuses on the development of its product candidate rencofilstat, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease. The company was founded on May 15, 2013 and is headquartered in Edison, NJ.